Damora Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Damora Therapeutics Inc
CIK #0001800315
EDGAR Form CIK 2011 - 2026
10-K [0001800315]
10-Q [0001800315]
3 [0001800315]
4 [0001800315]
8-K [0001800315]
D [0001800315]
SC 13D [0001800315]
SC 13G [0001800315]
Form 13D/13G Filer Form 13D/13G Subject Filed
Avoro Capital Advisors LLC Damora Therapeutics Inc [2026-05-15]
Venrock Healthcare Capital Partners III LP Galecto Inc [2026-02-17]
Jain Global LLC Galecto Inc [2026-02-17]
Paragon Therapeutics Inc Galecto Inc [2026-01-12]
Paramora Holding LLC Galecto Inc [2026-01-12]
Ikarian Capital LLC Galecto Inc [2025-12-05]
FMR LLC Galecto Inc [2025-12-05]
Fairmount Funds Management LLC Galecto Inc [2025-11-17]
Point72 Asset Management LP Galecto Inc [2025-11-13]
Sunstone Life Science Ventures A/S Galecto Inc [2024-11-07]
Otto Erik Galecto Inc [2023-10-03]
HBM Healthcare Investments Cayman Ltd Galecto Inc [2021-02-12]
Janus Henderson Group PLC Galecto Inc [2021-02-12]
Cormorant Asset Management LP Galecto Inc [2020-11-12]
Soleus Private Equity Fund I LP Galecto Inc [2020-11-12]
OrbiMed Advisors LLC Galecto Inc [2020-11-06]
Novo Holdings A/S Galecto Inc [2020-11-05]
Form 3/4/5 Subject 2011 - 2026
Damora Therapeutics Inc
Winslow Garrett
Burkavage Brian
Jarrett Jennifer
Turtle Cameron
Bruno Julianne
Cain Christopher W
Landsittel Michael
Kiselak Tomas
Fairmount Funds Management LLC
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
2026-03-23 Grant 37,313 $0.00
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
2026-03-23 Grant 37,313 $0.00
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
2026-03-23 Grant 250,000 $0.00
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
2026-03-23 Grant 37,313 $0.00
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
2026-03-23 Grant 37,313 $0.00
Damora Therapeutics Inc DMRA
Stock Option (right to buy) · derivative
2026-03-23 Grant 37,313 $0.00
Damora Therapeutics Inc GLTO
Common Stock
2026-02-09 Option exercise 5,809,000 $0.00
Damora Therapeutics Inc GLTO
Common Stock
2026-02-09 Option exercise 2,904,000 $0.00
Damora Therapeutics Inc GLTO
Common Stock
2026-02-09 Option exercise 129,000 $0.00
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
2026-02-09 Option exercise 129 $0.00
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
2026-02-09 Option exercise 5,809 $0.00
Damora Therapeutics Inc GLTO
Series C Preferred Stock · derivative
2026-02-09 Option exercise 2,904 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2026-01-05 Grant 528,603 $0.00
Damora Therapeutics Inc GLTO
Common Stock
2026-01-05 Grant 190,376 $0.00
Damora Therapeutics Inc GLTO
Common Stock
2026-01-05 Grant 264,629 $0.00
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
2026-01-05 Grant 444,209 $0.00
Damora Therapeutics Inc GLTO
Restricted Stock Units · derivative
2026-01-02 Option exercise 680 $0.00
Damora Therapeutics Inc GLTO
Restricted Stock Units · derivative
2026-01-02 Option exercise 374 $0.00
Damora Therapeutics Inc GLTO
Common Stock
2026-01-02 Option exercise 374
Damora Therapeutics Inc GLTO
Common Stock
2026-01-02 Sell 135 $21.41 2,890
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com